Kevin Kotler and 2 Others Buys $961K of Biodelivery Sciences International Inc (BDSI) — SEC Form 4, May 13, 2021
Open-Market Net Purchase · SEC Form 4
+$960,500
Equity position changed by +6.9%
Reporting Owners
Director
Director
Director
TXN 2021-05-13
·
FILED 2021-05-13
Equity Position
4.66M sh
4,355,689 → 4,655,689
Equity Change
+6.9%
shares held after vs before
Filing Lag
0 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owners
| Name | Relationship |
|---|---|
| Kevin Kotler CIK 0001601692 |
Director
|
| Broadfin Healthcare Master Fund Ltd CIK 0001511900 |
Director
|
| Broadfin Capital, LLC CIK 0001511901 |
Director
|
Kevin Kotler at Biodelivery Sciences International Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Biodelivery Sciences International Inc
| 2022-03-22 | Gift/Other | — | View |
| 2022-02-15 | - | — | View |
| 2022-01-31 | Exercise | — | View |
| 2021-11-22 | Buy | +$306,000 | View |
| 2021-11-15 | Buy | +$320,000 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1F2F3F4 | 2021-05-11 | P - Purchase | 150,000 A | $3.16 | +$474,000 | 4,505,689 | Indirect |
| Common StockF2F5F3F4 | 2021-05-12 | P - Purchase | 100,000 A | $3.24 | +$324,000 | 4,605,689 | Indirect |
| Common StockF2F6F3F4 | 2021-05-13 | P - Purchase | 50,000 A | $3.25 | +$162,500 | 4,655,689 | Indirect |
Footnotes (6)
- F1
- On May 11, 2021, the Reporting Person purchased an aggregate of 150,000 shares of the Issuer's Common Stock at a weighted average price of $3.16 per share. The highest purchase price for the Common Stock was $3.17 per share and the lowest purchase price was $3.07 per share. Show more
- F2
- The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in these footnotes. Show more
- F3
- 300,000 shares of Common Stock are held in the account of Broadfin Holdings, LLC., a private investment fund, and are deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Holdings, LLC. Show more
- F4
- 4,355,689 shares of Common Stock are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC, and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Broadfin Healthcare Master Fund, Ltd., Broadfin Capital, LLC, and Kevin Kotler affirmatively (i) disclaim beneficial ownership of the reportable securities, (ii) states that this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 ("Section 16") of the Securities Exchange Act of1934, as amended (the "Act") or any other purpose, except to the extent of their pecuniary interest therein, and (iii) disclaim being a "group" for purposes of Section 16. Show more
- F5
- On May 12, 2021, the Reporting Person purchased an aggregate of 100,000 shares of the Issuer's Common Stock at a weighted average price of $3.24 per share. The highest purchase price for the Common Stock was $3.28 per share and the lowest purchase price was $3.13 per share. Show more
- F6
- On May 13, 2021, the Reporting Person purchased an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $3.25 per share. The highest purchase price for the Common Stock was $3.27 per share and the lowest purchase price was $3.24 per share. Show more
Related filings at Biodelivery Sciences International Inc
Other insiders at Biodelivery Sciences International Inc
GET /v1/forms/4/0001103021-21-000046
API docs
View Original SEC Filing